November 2, 2023
Pharmazac was awarded the Salus Index 2016 Active Business Awards prize for its innovation in research and development of plant derived pharmaceutical products, pharmaceutical combinations and […]
November 2, 2023
Pharmazac launched the new product Apregalin® / pregabalin for the treatment of peripheral and central neuropathic pain in adults, for epilepsy as adjunctive therapy in adults […]
November 2, 2023
Pharmazac announces that its state-of-the-art Research and Development Lab at its headquarters received by the Greek Ministry of Health a GMP manufacturing license (clinical batches) for […]
November 2, 2023
Pharmazac S.A participates in CPhI 2019. You will find us at hall 91H stand 42, 5-7 November 2019 in Frankfurt – Gemany
November 2, 2023
Pharmazac is the official partner for Greece for the multinational companies Sintetica and Rokitan
November 2, 2023
November 2, 2023
PharmaZac sponsors the medical book “The Neuropsychology of Epilepsy” of Dr. P. Patrikelis Neuropsychologist Ph.D University of Ioannina Medical School and Dr. S. Gatzonis, Neurologist Dep. […]
November 2, 2023
Pharmazac S.A participates in the online CPhI festival of pharma 2020
November 2, 2023
Pharmazac has released the new product Calcium Folinate, an injectable solution 200mg/20ml Bt x 1 vial x20ml for intravenous or intramuscular use. Calcium Folinate / Pharmazac is the only available generic product in the Greek market.